摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{3-[4-(2,2-dimethyl-propionylamino)-2-(trifluoro-ethanesulfonylmethyl)-phenoxy]-4-methoxy-phenyl}-acetic acid | 1203503-74-5

中文名称
——
中文别名
——
英文名称
{3-[4-(2,2-dimethyl-propionylamino)-2-(trifluoro-ethanesulfonylmethyl)-phenoxy]-4-methoxy-phenyl}-acetic acid
英文别名
2-[3-[4-(2,2-Dimethylpropanoylamino)-2-(2,2,2-trifluoroethylsulfonylmethyl)phenoxy]-4-methoxyphenyl]acetic acid
{3-[4-(2,2-dimethyl-propionylamino)-2-(trifluoro-ethanesulfonylmethyl)-phenoxy]-4-methoxy-phenyl}-acetic acid化学式
CAS
1203503-74-5
化学式
C23H26F3NO7S
mdl
——
分子量
517.523
InChiKey
NDXBDDNNYODIHO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    127
  • 氢给体数:
    2
  • 氢受体数:
    10

文献信息

  • ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    申请人:HUTCHINSON John Howard
    公开号:US20100004331A1
    公开(公告)日:2010-01-07
    Described herein are compounds that are antagonists of PGD 2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD 2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD 2 -dependent or PGD 2 -mediated conditions or diseases.
    本文描述了一些作为PGD2受体拮抗剂的化合物。还描述了包括本文描述的化合物的药物组合物,以及使用这些PGD2受体拮抗剂的方法,单独或与其他化合物结合,用于治疗呼吸系统、心血管系统和其他依赖或介导于PGD2的疾病或病况。
  • Antagonists of Prostaglandin D2 Receptors
    申请人:Hutchinson John Howard
    公开号:US20110190227A1
    公开(公告)日:2011-08-04
    Described herein are compounds that are antagonists of PGD 2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists Of PGD 2 receptors. Also described herein are methods of using such antagonists of PGD 2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD 2 -dependent or PGD 2 -mediated conditions or diseases.
    本文描述了一些PGD2受体拮抗剂化合物。还描述了包括这些化合物的药物组合物和药物,这些药物是PGD2受体拮抗剂。本文还描述了使用这些PGD2受体拮抗剂的方法,单独或与其他化合物结合,用于治疗呼吸系统、心血管系统和其他依赖于PGD2或通过PGD2介导的疾病或疾病的方法。
  • US8071807B2
    申请人:——
    公开号:US8071807B2
    公开(公告)日:2011-12-06
  • [EN] ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS<br/>[FR] ANTAGONISTES DES RÉCEPTEURS DE LA PROSTAGLANDINE D2
    申请人:AMIRA PHARMACEUTICALS INC
    公开号:WO2010003127A2
    公开(公告)日:2010-01-07
    Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists Of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
查看更多